Why can't PVC be replaced by other more environmentally friendly plastics for pharmaceutical blister packaging?

PVC remains the mainstream material for pharmaceutical blister packaging and is difficult to completely replace with environmentally friendly plastics. The core reason lies in its overwhelming advantages in overall performance, cost, processing, compliance, and the supply chain. Environmentally friendly materials still have shortcomings in key indicators.

I. The Irreplaceable Core Advantages of PVC

1. Extreme Cost-Effectiveness (The Core Barrier)

Extremely Low Cost: The cost of rigid PVC sheets is only 60%–70% of that of PET and PP, with abundant raw materials and mature production.

High Production Efficiency: Thermoforming speed is 100–200 sheets/minute, suitable for high-speed production lines, and the molding qualification rate is 5%–8% higher than PET.

Strong Heat-Sealing Compatibility: Stable heat-sealing with PTP aluminum foil at 150–180℃, with a peel force of 5–15N/15mm, balancing sealing and easy tearing.

2. Mature Compliance and Safety System

Pharmaceutical-grade PVC has been used for over 30 years, with well-established standards including domestic YBB 00242003 and EU CEP.

High purity, free of harmful plasticizers/heavy metals, suitable for direct contact with pharmaceuticals, with complete compatibility testing and certification.

Alternative materials (such as new PET/PP/PLA) require re-testing for compatibility, toxicology, and registration, taking 6-12 months and incurring extremely high costs.

3. Comprehensive Performance Precisely Matches Pharmaceutical Needs

Transparent + Rigid + Tough: Light transmittance ≥90%, good structural strength, resistant to bending and compression, protecting pharmaceutical transportation safety.

Highly Modifiable: Ordinary PVC meets the needs of over 80% of conventional pharmaceuticals; composite PVDC/EVOH can significantly improve barrier properties, suitable for highly sensitive drugs.

Radiation Resistant: Compatible with gamma rays and electron beam sterilization without affecting performance.

II. Fatal Shortcomings of Environmentally Friendly Alternative Materials

1. PET/PP: Performance-Cost Imbalance

PET: Good barrier properties but narrow thermoforming window, brittle, high cost, and low molding pass rate.

PP: Environmentally friendly but poor transparency, weak heat-sealing properties, poor compatibility with aluminum foil, requiring specialized equipment and coatings.

Neither can simultaneously match PVC in terms of cost, molding, and heat sealing.

2. Biodegradable Materials such as PLA/PBAT: Performance Substandard

Poor Thermal Stability: PLA's heat distortion temperature is only 55℃, making it unsuitable for conventional **150℃+** heat sealing.

Insufficient Barrier Properties: Oxygen/water vapor barrier properties are far lower than PVC/PVDC, making it difficult to guarantee the shelf life of pharmaceuticals.

High Cost: 30%–50% more expensive than PVC, and poor process compatibility, making large-scale production difficult.

In short: PVC is the optimal solution in terms of cost, efficiency, compliance, and performance for pharmaceutical blister packaging. Environmentally friendly materials can currently only supplement specific scenarios and cannot completely replace it.